NUVB

Nuvation Bio Inc

• Simply Wall St·3d ago

  How Does Nuvation Bio’s (NUVB) IBTROZI Update Reframe Its Long-Term Oncology Investment Narrative?

• Barron‘s·05/15 21:59

  Stanley Druckenmiller Just Exited Alphabet. TCI Fund Management Is Buying.

• Seeking Alpha·05/15 01:06

  Tracking David Abrams' Abrams Capital Management Portfolio - Q1 2026 Update

• Dow Jones·05/13 21:37

  Nuvation Bio Collaborates With Thermo Fisher Scientific For Lung Cancer Treatment

• TipRanks·05/13 20:41

  Nuvation Bio collaborating with Thermo Fisher to manufacture Ibtrozi in NSCLC

• PR Newswire·05/13 20:05

  Nuvation Bio to Collaborate with Thermo Fisher Scientific for U.S.-Based Manufacturing of IBTROZI® for ROS1-Positive Non-Small Cell Lung Cancer

• Simply Wall St·05/11 04:29

  A Look At Nuvation Bio (NUVB) Valuation After Profit Shift And Taletrectinib FDA And Guideline Milestones

• TipRanks·05/11 00:24

  Nuvation Bio Signals Durable Momentum in Earnings Call

• Simply Wall St·05/10 00:52

  Why Nuvation Bio (NUVB) Is Up 8.1% After FDA Accepts IBTROZI Label Update, Strong Q1 Results

• Simply Wall St·05/08 14:55

  Results: Nuvation Bio Inc. Confounded Analyst Expectations With A Surprise Profit

• TipRanks·05/07 06:20

  Nuvation Bio: FDA accepts sNDA with updated data for IBTROZI

• Seeking Alpha·05/06 15:55

  Nuvation bid to expand Ibtrozi label undergoes FDA review

• PR Newswire·05/06 12:00

  Nuvation Bio Announces FDA Acceptance of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in Advanced ROS1-Positive Non-Small Cell Lung Cancer

• PR Newswire·05/05 20:05

  Nuvation Bio to Participate in Upcoming Investor Conferences

• Dow Jones·05/05 15:45

  Nuvation Bio Price Target Maintained With a $20.00/Share by RBC Capital